2014, Journal of Allergy and Clinical Immunology Citation Excerpt : When the inhibitor was administered in the primary challenge phase, a significant reduction in BAL fluid eotaxin levels was demonstrated, which is similar to the inhibition of eotaxin triggered by IL-13 in lung fibroblasts.20,22 ...